Serinus Biosciences YC 申请

Summer 2022Active

Serinus Biosciences 在 Summer 2022 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Summer 2022
行业: HealthcareTherapeutics
团队规模: 6
状态: Active
已发布: 2022

创始人

Adam YaariFounder/CEO
Maxwell ShermanFounder/CTO

Serinus Biosciences 做什么

Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.

Serinus Biosciences 的 YC 申请，重建版

Y Combinator 申请

Serinus Biosciences，Summer 2022 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Serinus Biosciences

Describe what your company does in 50 characters or less.

Combinations therapy by rational design

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI platform that designs combination therapies to overcome cancer treatment resistance. Our system uses decades of system biology knowledge to model how cancer evolves escape routes to therapies, allowing us to propose molecule combinations that are more effective and safer. The output is explainable, letting researchers and clinicians understand why the selected combinations work.

Where do you live now, and where would the company be based after YC?

We live and operate in New York, NY, USA, and plan to keep the company based here after YC.

Explain your decision regarding location.

New York is a biotech and healthcare innovation hub with access to top academic partners and talent. Staying here lets us collaborate closely with our scientific advisors and prospective customers while benefiting from YC's remote-friendly approach.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Serinus Biosciences 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Serinus Biosciences 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Serinus Biosciences 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Serinus Biosciences 是哪个 YC 批次的？

Serinus Biosciences 是 Y Combinator Summer 2022 批次的成员。

谁创立了 Serinus Biosciences？

Serinus Biosciences 由 Adam Yaari, Maxwell Sherman 创立。

Serinus Biosciences 做什么？